Hepatitis C Drugs Market to Undertake Strapping Growth by the End 2026
Antiviral drugs are used for the treatment of infection caused due to hepatitis C. These drugs inhibit the growth of protease or polymerase enzyme of the virus. However, there is no vaccine for the prevention infections caused due to hepatitis C virus, which offers lucrative growth opportunities for market players. Increasing number of people suffering from chronic hepatitis C is expected to boost growth of the global hepatitis C drug market. For instance, according to the World Health Organization (WHO),...
View full press release